Inspire Medical Systems(INSP)
$60.54-1.57 (-2.53%)
INSP
Inspire Medical Systems stock forecast
$60.54
At close:-1.57 (-2.53%)
Want to see INSP full AI Analyst Report?
Inspire Medical Systems (INSP) Stock Forecast & Price Target
815 Followers
INSP Analyst Ratings
Hold
4Buy8Hold2Sell
Based on 14 analysts giving stock ratings to Inspire Medical Systems in the past 3 months
INSP Stock 12 Month Forecast
Average Price Target
$73.08â–²(20.71% Upside)Based on 14 Wall Street analysts offering 12 month price targets for Inspire Medical Systems in the last 3 months. The average price target is $73.08 with a high forecast of $97.00 and a low forecast of $45.00. The average price target represents a 20.71% change from the last price of $60.54.
Past 12 Months12 Month ForecastJan2026Oct2026
High$97.00
Average$73.08
Low$45.00
Highest Price TargetHighest$97.00Average Price Target$73.08Lowest Price TargetLowest$45.00
Detailed List of Analyst Forecasts​
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Patrick Wood | UBS | $40→$45 | sell | -25.67%Downside | Reiterated | 11/06/26 | ||
| Christopher Pasquale | Barclays | $65→$62 | sell | 2.41%Upside | Reiterated | 11/03/26 | ||
| Brett Fishbin | KeyBanc | ― | hold | ― | Reiterated | 11/03/26 | ||
| David Rescott | Robert W. Baird | $73→$77 | hold | 27.19%Upside | Reiterated | 11/03/26 | ||
| Adam Maeder | Piper Sandler | $60→$70 | hold | 15.63%Upside | Reiterated | 11/03/26 | ||
| Robbie Marcus | J.P. Morgan | $60→$65 | hold | 7.37%Upside | Assigned | 11/03/26 | ||
| Suraj Kalia | Oppenheimer | $85 | buy | 40.40%Upside | Reiterated | 11/03/26 | ||
| Jonathan Block | Stifel Nicolaus | $85 | buy | 40.40%Upside | Reiterated | 11/03/26 | ||
| Larry Biegelsen | Wells Fargo | $56→$69 | hold | 13.97%Upside | Reiterated | 11/02/26 | ||
| Kendall Au | RBC Capital | $75 | hold | 23.89%Upside | Reiterated | 11/02/26 | ||
| Richard Newitter | Truist Financial | $62→$78 | hold | 28.84%Upside | Reiterated | 10/14/26 | ||
| Anthony Petrone | Mizuho Securities | $65→$75 | buy | 23.89%Upside | Assigned | 10/13/26 | ||
 Unknown AnalystNot Ranked | Leerink Partners | $59→$67 | hold | 10.67%Upside | Reiterated | 10/12/26 | ||
| Keith Hinton | Freedom Capital Markets | $71→$97 | buy | 60.22%Upside | Reiterated | 09/21/26 | ||
| Travis Steed | Bank of America Securities | $39→$45 | sell | -25.67%Downside | Reiterated | 08/04/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Patrick WoodUBS | SellReiterated$40→$45 | 11/06/26 | -25.67%Downside | ||
| Christopher PasqualeBarclays | SellReiterated$65→$62 | 11/03/26 | 2.41%Upside | ||
| Brett FishbinKeyBanc | HoldReiterated | 11/03/26 | ― | ||
| David RescottRobert W. Baird | HoldReiterated$73→$77 | 11/03/26 | 27.19%Upside | ||
| Adam MaederPiper Sandler | HoldReiterated$60→$70 | 11/03/26 | 15.63%Upside | ||
| Robbie MarcusJ.P. Morgan | HoldAssigned$60→$65 | 11/03/26 | 7.37%Upside | ||
| Suraj KaliaOppenheimer | BuyReiterated$85 | 11/03/26 | 40.40%Upside | ||
| Jonathan BlockStifel Nicolaus | BuyReiterated$85 | 11/03/26 | 40.40%Upside | ||
| Larry BiegelsenWells Fargo | HoldReiterated$56→$69 | 11/02/26 | 13.97%Upside | ||
| Kendall AuRBC Capital | HoldReiterated$75 | 11/02/26 | 23.89%Upside | ||
| Richard NewitterTruist Financial | HoldReiterated$62→$78 | 10/14/26 | 28.84%Upside | ||
| Anthony PetroneMizuho Securities | BuyAssigned$65→$75 | 10/13/26 | 23.89%Upside | ||
| Unknown AnalystLeerink PartnersNot Ranked | HoldReiterated$59→$67 | 10/12/26 | 10.67%Upside | ||
| Keith HintonFreedom Capital Markets | BuyReiterated$71→$97 | 09/21/26 | 60.22%Upside | ||
| Travis SteedBank of America Securities | SellReiterated$39→$45 | 08/04/26 | -25.67%Downside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Inspire Medical Systems
3 Months
Success Rate13/25 ratings generated profit
52%
Average Return
+2.95%
Copying Jonathan Block's trades and holding each position for 3 Months would result in 52.00% of your transactions generating a profit, with an average return of +2.95% per trade.
1 Year
Success Rate14/25 ratings generated profit
56%
Average Return
+26.32%
Copying Jonathan Block's trades and holding each position for 1 Year would result in 56.00% of your transactions generating a profit, with an average return of +26.32% per trade.
2 Years
Success Rate14/25 ratings generated profit
56%
Average Return
+51.06%
Copying Jonathan Block's trades and holding each position for 2 Years would result in 56.00% of your transactions generating a profit, with an average return of +51.06% per trade.
INSP Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 4 | 4 | 6 | 7 | 6 |
| Hold | 14 | 12 | 11 | 12 | 10 |
| Sell | 3 | 3 | 3 | 2 | 3 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 21 | 19 | 20 | 21 | 19 |
In the current month, INSP has received 6 Buy Ratings, 10 Hold Ratings, and 3 Sell Ratings. INSP average Analyst price target in the past 3 months is 73.08.
INSP Financial Forecast
High$0.99
Consensus$0.92
Low$0.85
INSP Earnings Forecast
Next quarter’s earnings estimate for INSP is $0.92 with a range of $0.85 to $0.99. The previous quarter’s EPS was $0.14. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
High$252M
Consensus$244M
Low$238M
INSP Sales Forecast
Next quarter’s sales forecast for INSP is $243.66M with a range of $238.22M to $251.60M. The previous quarter’s sales results were $206.69M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
INSP Stock Forecast FAQ
What is INSP’s average 12-month price target, according to analysts?
Based on analyst ratings, Inspire Medical Systems’s 12-month average price target is $73.08.
What is INSP’s upside potential, based on the analysts’ average price target?
Inspire Medical Systems has 20.71% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is INSP a Buy, Sell or Hold?
Inspire Medical Systems has a consensus rating of Hold which is based on 4 buy ratings, 8 hold ratings and 2 sell ratings.
What is Inspire Medical Systems’s price target?
The average price target for Inspire Medical Systems is $73.08. This is based on 14 12-month price targets, issued in the past 3 months. The highest analyst price target is $97.00, the lowest forecast is $45.00. The average price target represents a 20.71% increase from the current price of $60.54.
What do analysts say about Inspire Medical Systems?
Inspire Medical Systems’s analyst rating consensus is a Hold. This is based on the ratings of 14 Wall Street analysts.
How can I buy shares of INSP?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
